Showing results (71-80 of 80) with videos related to

Sort By:
Pageof 8
You have reached the last page of results.This site can display upto 80 results.
Carcinogenesis|February 22, 2021
Oncogenic transcriptomic profile is sustained in the liver after the eradication of the hepatitis C virusHaruhiko Takeda, Atsushi Takai, Eriko Iguchi, et al.
The Journal of Pathology|June 22, 2023
ELF3 suppresses gallbladder cancer development through downregulation of the EREG/EGFR/mTOR complex 1 signalling pathwayTakeharu Nakamura, Yoshihiro Nishikawa, Masahiro Shiokawa, et al.
Nihon Shokakibyo Gakkai Zasshi = the Japanese Journal of Gastro-Enterology|September 6, 2013
[A case of α-fetoprotein-producing hepatoid adenocarcinoma of the stomach with spontaneous rupture of multiple liver metastases]Haruhiko Takeda, Ryuichi Kita, Takashi Kanesaka, et al.
Cancer Research|April 1, 2022
Expansion of Gastric Intestinal Metaplasia with Copy Number Aberrations Contributes to Field CancerizationKen Kumagai, Takahiro Shimizu, Atsushi Takai, et al.
The Journal of Pathology|February 16, 2024
Integrated analyses of the genetic and clinicopathological features of cholangiolocarcinoma: cholangiolocarcinoma may be characterized by mismatch-repair deficiencyKenta Makino, Takamichi Ishii, Haruhiko Takeda, et al.
Journal of Gastroenterology|September 17, 2024
CRAFITY score as a predictive marker for refractoriness to atezolizumab plus bevacizumab therapy in hepatocellular carcinoma: a multicenter retrospective studyMasayuki Ueno, Haruhiko Takeda, Atsushi Takai, et al.
Hepatology (Baltimore, Md.)|January 15, 2026
NRF2-COX2-PGE2 axis drives immune cold tumors and predicts resistance to combination immunotherapy in hepatocellular carcinomaShuhei Yamamoto, Takahiro Kodama, Akifumi Kuwano, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology|September 13, 2025
Lenvatinib Versus Atezolizumab Plus Bevacizumab as First-Line Treatment for Advanced Hepatocellular Carcinoma With a CRAFITY Score of 2: A Multi-Center Retrospective StudyMasayuki Ueno, Haruhiko Takeda, Atsushi Takai, et al.
Cancer Research|October 17, 2020
Hes1 Is Essential in Proliferating Ductal Cell-Mediated Development of Intrahepatic CholangiocarcinomaTomoaki Matsumori, Yuzo Kodama, Atsushi Takai, et al.
Liver Cancer|July 24, 2026
Atezolizumab plus Bevacizumab versus Lenvatinib as First-Line Treatment for Unresectable Hepatocellular Carcinoma Stratified by the CRAFITY Score: An International Multicenter StudyMasayuki Ueno, Yung-Yeh Su, Atsushi Takai, et al.
Pageof 8